Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trialTao Jiang, Shengxiang Ren, Yongqian Shu et al.|Signal Transduction and Targeted Therapy|2021Cited by 94
Alterations of brain activity in patients with alcohol use disorder: a resting-state fMRI studyXia Ruan, Tiantian Zhou, Zhi-yan Song et al.|BMC Psychiatry|2023Cited by 13
Aging of alveolar type 2 cells induced by <i>Lonp1</i> deficiency exacerbates pulmonary fibrosisWeiwei Zhu, Jie Zhang, Chunting Tan|Biomolecules and Biomedicine|2024Cited by 4